Dr. Rebecca Martin – Global Health Publications


U.S. Centers for Disease Control and Prevention and its Partners’ Contributions to Global Health Security.
Tappero, JT, Cassell CH, Bunnell R, Angulo FJ, Craig A, Pesik N, Dahl BA, Ijazz K, Jafari H, and Martin R.
Emerging Infectious Diseases 2017; Volume 23, Supplement Issue: S5-S14.

Control of Japanese encephalitis in Asia: the time is now.external icon
Hills S, Martin R, Marfin A, Fischer M.
Expert Review of Anti Infective Therapy. 2014 Aug; 12(8): 901-904.

Seroepidemiology of diphtheria and tetanus among children and young adults in Tajikistan: Nationwide population-based survey, 2010. external icon
Khetsuriani N, Zakikhany K, Jabirov S, Martin, RM.
Vaccine 2013, 31(42).

Lessons learnt from pandemic A(H1N1) 2009 influenza vaccination. Highlights of a European workshop in Brussels (22 March 2010). external icon
Hanquet G, Van Damme P, Brasseur D, Martin RM, Neels P.
Vaccine 2010, 29(3): 370-7.

Guidelines for Conducting HIV Sentinel Serosurveys among Pregnant Women and Other Groups.
Martin RM, Murrill CS, Calleja T.
UNAIDS/03.49E 2003.

Guidelines for Using HIV Testing Technologies in Surveillance: Selection, Evaluation, and Implementation.
Martin RM, Murrill CS.
WHO/UNAIDS and CDC 2001.


Fifty Years of Immunization at CDC, 1966-2105. external icon
Mast EE, Cochi SL, Kew OM, Cairns KL, Bloland PB, and Martin R.
Public Health Reports 2017; Volume 132(I): 18-26.

Zika Virus —10 Public Health Achievements in 2016 and Future Priorities.
Oussayef NI, Pillai SK, Honein M, Martin RM, Jameson DJ et. al.
Morbidity and Mortality Weekly Report 2017, 65(52).

CDC’s Strategic Framework for Global Immunization, 2016-2020. pdf icon
Centers for Disease Control and Prevention.
May 2016 www.cdc.gov/globalhealth/immunization.

Immunization in Europe.
Salisbury D, Martin RM, Lopalco P.
Plotkin’s Vaccines 6th Edition. Plotkin S, Orenstein, W, and Offitt P. 2012 Oct; Chapter 68: 1334-1352.

Addressing vaccine-preventable diseases in areas with high coverage in the European Region: thematic movements and cumulative moments. pdf iconexternal icon
Martin RM.
SAGE 2010.

European Immunization Week goes viral. external icon
Martin R, Nørgaard O, Lazarus.
Eurosurveillance 2009; 14(16) – Article 1.

Comparison of Two Survey Methodologies to Assess Vaccination Coverage. external icon
Luman E, Worku A, Berhane Y, Martin R, Cairns L.
International Journal of Epidemiology 2007; Jun; 36(3):633-41.

Estimating the Haemophilus influenzae type b (Hib) disease burden and the impact of Hib vaccine in Fiji. external icon
Wilson N, Mansoor O, Wenger J, Martin R, Zanardi L, et al.
Vaccine 2003; 21:1907–1912.

Evaluation of Kenya’s 2002 Supplemental and Routine Measles Immunization Activities.
Kenya Ministry of Health, WHO (Rebecca Martin), and CDC.
December 2002.


The polio endgame: securing a world free of all polioviruses.external icon
Zaffran M, McGovern M, Hossaini R, Martin RM, Wenger J.
The Lancet 6 January 2018 391(10115)

Globally Synchronized Switch – Another Milestone Towards Achieving Polio Eradication. external icon
Wassilak SG, Vertefeuille JF, Martin R.
JAMA Pediatrics. 2016 Oct 1; 170 (10): 927-928.

Challenges of Maintaining Polio-free Status of the European Region.external icon
Khetsuriani N, Pfeifer D, Deshevoi S, Martin RM.
The Journal of Infectious Diseases 2014, 210 suppl 1:5194-207.

The role of older children and adults in wild poliovirus transmission. external icon
Blake IM, Martin RM, Goel A, Grassly NC.
PNAS 2014, 111(29).

Population immunity to polioviruses in the context of a large-scale wild poliovirus type 1 outbreak in Tajikistan 2010. external icon
Khetsuriani N, Pallansch MA, Jabirov S, Martin RM.
Vaccine 2013, 31(42).

World Health Organization Regional Assessments of the Risks of Poliovirus Outbreaks. external icon
Lowther SA, Roesel S, O’Connor P, Martin R.
Risk Analysis April 2013; Volume 33, Issue 4: 664-679.

Synchronized Polio Supplementary Immunization Activities in the Central Asian Republics, Azerbaijan and the Russian Federation. external icon
Huseynov S,Deshevoi S, Jankovic D, Martin RM.

Outbreaks Following Wild Poliovirus Importations — Europe, Africa, and Asia, January 2009–September 2010. Morbidity and Mortality Weekly Report. 2010; 59(43); 1393-1399.


Nationwide Rubella Epidemic – Japan, 2013.
Tanaka-Taya K, Satoh H, Arai S, Martin RM, et. al.
Morbidity and Mortality Weekly Report. 2013, 62(23): 457-462.

Increased Transmission and Outbreaks of Measles – European Region, 2011. external icon 
Martin RM, Jankovic D, Goel A, Ogbuano I.
JAMA 2012, 307(5): 450-52.

Research priorities for global measles and rubella control and eradication. external icon 
Goodson JL, Chu SY, Rota PA, Martin RM, Strebel P.
Vaccine 2012, 30(32): 4709-16.

What Will It Take to Achieve Measles Elimination in the World Health Organization European Region: Progress From 2003–2009 and Essential Accelerated Actions. external icon
Martin RM, Wassilak S, Emiroglu N, Uzicanin A, Deshevoi S, Jankovic D, Goel A, Khetsuriani N.
Journal of Infectious Diseases. 2011, 204(suppl 1): S325-S334.

Molecular Genotyping and Epidemiology of Measles Virus Transmission in the World Health Organization European Region, 2007–2009. external icon
Mankertz A, Mulder MN, Shulga S, Kremer JR, Brown KE, Santibanez S, Muller CP, Tikhonova N, Lipskaya G, Jankovic D, Khetsuriani N, Martin RM, Gavrilin E.
Journal of Infectious Diseases. 2011, 204 (suppl 1): S335-S342.

Supplementary Immunization Activities to Achieve Measles Elimination: Experience of the European Regionexternal icon.
Khetsuriani N, Deshevoi S, Goel A, Spika J, Martin RM, Emiroglu N.
Journal of Infectious Diseases. 2011 204(suppl 1): S343-S352.

Status of Rubella and Congenital Rubella Syndrome Surveillance, 2005–2009, the World Health Organization European Regionexternal icon.
Zimmerman LA, Muscat M, Jankovic D, Goel A, Bang H, Khetsuriani N, Martin RM.
Journal of Infectious Diseases. 2011, 204(suppl 1): S381-S388.

Impact of unfounded vaccine safety concerns on the nationwide measles-rubella immunization campaign, Georgia, 2008. external icon
Khetsuriani N, Imnadze P, Baidoshvili L, Jabidze L, Tatishili N, Kurtsikashvili G, Lezhava T, Laurent E, Martin R.
Vaccine 2010, Sep 7;28(39):6455-62.

Spotlight on measles 2010: Measles elimination in Europe – a new commitment to meet the goal by 2015. external icon
Steffens I, Martin R, Lopalco PL.
Eurosurveillance 2010; 15(50) – Article 1.

Measles still spreads in Europe: who is responsible for the failure to vaccinate?external icon
Lopalco PL, Martin R.
Eurosurveillance 2010; 15(17) – Article 2.

Prevention of congenital rubella and congenital varicella in Europe. external icon
Martin RM.
Eurosurveillance Bull 2009, 14(14):10.

Are Rubella Surveillance and Reporting Practices Sufficient to Document Progress Toward the 2010 Elimination Goal in the World Health Organization (WHO) European Region (EUR)? external icon
Jankovic D, Martin RM, Muscat M, Zimmerman L.
IDSA 2009.

Approaching measles and rubella elimination in the European.external icon
Martin R, Deshevoi S, Buddha N, Jankovic D.
Eurosurveillance 2009; 1, 14(50) – Article 1.

Surveillance Guidelines for Measles, Rubella and Congenital Rubella Syndrome in the WHO European Region.

Progress Towards Measles Elimination — European Region, 2005—2008.
Martin R, Khetsuriani N, Deshevoi S, Jankovic D, Goel A, S Wassilak.
Morbidity and Mortality Weekly Report 2009; 58(06); 142-145.

Measles Supplemental Immunization Activities Improve Measles Vaccine Coverage and Equity: Evidence from Kenya, 2002.external icon
Vijayraghavan M, Martin R, Sangrujee N, Muchuri S., et.al.
Health Policy 2007; 83(1): 27-36.

Public-health impact of accelerated measles control in the WHO African Region 2000-03. external icon
Otten M, Kezaala R, Fall A, Masresha B, Martin R, Cairns, L, et al.
Lancet 2005; 366: 832-839.

Eritrea Measles and Vitamin A Supplemental Immunization Activities in 2003: Post-Campaign Evaluation Report.
Eritrean Ministry of Health, WHO (Rebecca Martin), UNICEF.
March 2004.

Page last reviewed: January 29, 2020
Content source: Global Health